Trial: 201909063

A Phase I, First-In-Human, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Phase

I

Principal Investigator

Pedersen, Katrina

Disease Site

Colon; Esophagus; Other Digestive Organ; Rectum; Stomach

Learn more about this study at: clinicaltrials.gov